Skip to main content
Log in

Folic acid, vitamin B12, and homocysteine levels during fasting and after methionine load in patients with Type 1 diabetes mellitus

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Aims: To assess plasma concentrations of folic acid, vitamin B12, and total plasma homocysteine (tHCY) during fasting and after methionine load in young patients with Type 1 diabetes mellitus (T1DM). Methods: We enrolled 41 young patients with T1DM without any sign of microvascular complications and 123 healthy controls in a 1:3 case-control study. Fasting and post-methionine load (PML) tHCY, folic acid, and vitamin B12 levels were measured in both groups. Data regarding chronological age, metabolic control (assessed by mean values of glycated hemoglobin in the last 12 months) and disease duration were also recorded. Results: Fasting and PML tHCY levels were significantly lower in patients than in controls: 7.3±2.7 μmol/l vs 8.3±2.5 μmol/l (p=0.01), and 16.7±5.8 μmol/l vs 17.3±4.3 μmol/l (p=0.01), respectively. No correlation was found between fasting and PML tHCY levels and chronological age, disease duration, metabolic control, and insulin requirement. Patients had significantly higher vitamin B12 levels compared to controls: 767±318 pg/ml vs 628±236 pg/ml (p=0.003), while folic acid turned out to be lower in patients than in controls: 5.3±1.9 nmol/l vs 7.5±2.6 nmol/l (p<0.0001). Conclusions: Adolescents and young adults with T1DM without microvascular complications showed lower tHCY both during fasting and after methionine load. Lower folate concentrations in these patients might benefit from food fortification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999, 19: 217–46.

    Article  CAS  PubMed  Google Scholar 

  2. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997, 277: 1775–81.

    CAS  Google Scholar 

  3. Selhub J. Public health significance of elevated homocysteine. Food Nutr Bull 2008, 29 (Suppl 2): S116–25.

    PubMed  Google Scholar 

  4. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44 (Suppl 2): S14–21.

    Article  PubMed  Google Scholar 

  5. Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 1997, 20: 1880–6.

    Article  CAS  PubMed  Google Scholar 

  6. CroninCC, McPartlin JM, Barry DG, Ferriss JB, Scott JM, Weir DG. Plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 1998, 21: 1843–7.

    Article  PubMed  Google Scholar 

  7. Pavía C, Ferrer I, Valls C, Artuch R, Colomé C, Vilaseca MA. Total homocysteine in patients with type 1 diabetes. Diabetes Care 2000, 23: 84–7.

    Article  PubMed  Google Scholar 

  8. Wiltshire E, Thomas DW, Baghurst P, Couper J. Reduced total plasma homocyst(e)ine in children and adolescents with type 1 diabetes. J Pediatr 2001, 138: 888–93.

    Article  CAS  PubMed  Google Scholar 

  9. Salardi S, Cacciari E, Sassi S, et al. Homocysteinemia, serum folate and vitamin B12 in very young patients with diabetes mellitus type 1. J Pediatr Endocrinol Metab 2000, 13: 1621–7.

    Article  CAS  PubMed  Google Scholar 

  10. Cotellessa M, Minniti G, Cerone R, Prigione F, Calevo MG, Lorini R. Low total plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 2001, 24: 969–71.

    Article  CAS  PubMed  Google Scholar 

  11. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20 (Suppl 1): 1183–97.

    Google Scholar 

  12. Minniti G, Cerone R, Piana A, Armani U, Lorini R. Plasma and serum total homocysteine concentrations in paediatric patients, evaluated by high-performance liquid chromatography with fluorescence. Clin Chem Lab Med 2000, 38: 675–6.

    Article  CAS  PubMed  Google Scholar 

  13. Hoey L, McNulty H, Askin N, et al. Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults. Am J Clin Nutr 2007, 86: 1405–13.

    CAS  PubMed  Google Scholar 

  14. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999, 340: 1449–54.

    Article  CAS  PubMed  Google Scholar 

  15. Chiarelli F, Pomilio M, Mohn A et al. Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy. J Pediatr 2000, 137: 386–92.

    Article  CAS  PubMed  Google Scholar 

  16. Veldman BA, Vervoort G, Blom H, Smits P. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance. Diabet Med 2005, 22: 301–5.

    Article  CAS  PubMed  Google Scholar 

  17. Matteucci E, Rossi L, Mariani S et al. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives. Nutr Metab Cardiovasc Dis 2002, 12: 184–9.

    CAS  PubMed  Google Scholar 

  18. Wollesen F, Brattström L, Refsum H, Ueland PM, Berglund L, Berne C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999, 55: 1028–35.

    Article  CAS  PubMed  Google Scholar 

  19. Smulders YM, Rakic M, Slaats EH, et al. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care 1999, 22: 125–32.

    CAS  Google Scholar 

  20. Wotherspoon F, Laight DW, Browne DL, et al. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria. Diabet Med 2006, 23: 1350–6.

    Article  CAS  PubMed  Google Scholar 

  21. Cerone R, Minniti G, Piana A, Armani U, Lorini R. Mild hyperhomocysteinemia: vitamin supplementation or not? Am J Clin Nutr 2001, 74: 271–2.

    CAS  PubMed  Google Scholar 

  22. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274: 1049–57.

    CAS  Google Scholar 

  23. Wotherspoon F, Laight DW, Turner C, et al. The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria. Int J Clin Pract 2008, 62: 569–74.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. G. Calevo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giannattasio, A., Calevo, M.G., Minniti, G. et al. Folic acid, vitamin B12, and homocysteine levels during fasting and after methionine load in patients with Type 1 diabetes mellitus. J Endocrinol Invest 33, 297–299 (2010). https://doi.org/10.1007/BF03346589

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346589

Keywords

Navigation